How much power should the military have over civilian affairs and how much should public health have over military affairs – let’s put that in the context of the rise and fall of Moderna
Regular readers will be familiar with my view that the reason that governments and health regulatory agencies failed in their duties to monitor and control the quality of injections badly made by Moderna and Pfizer is because the injections remained the property of the US military until they were injected into arms.
Others have explained how the use of emergency powers usually activated during times of war, were used to manufacture and distribute the injections.
Conspiracy hypothesis: The US military has an annual budget of close to a trillion bucks a year. If you capitalize that at 5%, you can “value” this at 20 trillion dollars – 6-7 times the size of the largest US company. - Apple – which is capitalized at around 3 trillion bucks.
Leaving aside the money flows between defence suppliers and contractors, there is a chain of command within the US military that controls a budget of tens of billions that interacts with the health industry.
We know that the State Department, CIA, USAID plus other federal agencies coordinate to roll-out preferred foreign policies and turn countries into US colonies – like Ukraine. All with taxpayers’ money and with no democratic accountability whatsoever. These “entities” operate with impunity in every country in which they operate with scant regard for the national laws of countries.
It would be interesting to see a list of the wealthiest military personnel and the sources of their wealth. What e do know is that there is a trail of money flowing between health regulators, drug companies, medical practitioners and the MSM that does not result in better health outcomes.
The complete and utter failure of mRNA technology is a case in point. Here I outline some of the issues around the trail of money that flows between the military, its subcontractors, the NIH, big pharma and individuals who facilitate the “game of death”.
Here’s a back story around Moderna. Let’s start here with a backstory of CEO Bancel and his involvement with the Wuhan Institute of Virology.
The French Connection: from the Wuhan Lab to Moderna. (substack.com)
“In 2004 the Chinese contacted the French company bioMerieux owned by Alain Merieux, (who is a personal friend of now dictator Xi Jinping) to design a level 4 bio facility in Wuhan,”
“This facility would take a full ten years to come to fruition, but during that time, the now CEO of Moderna was formerly the CEO of bioMerieux (2007-2011) through which time he overseen the design of the now infamous Wuhan lab.”
Sasha Latypova has done a deep dive – in two parts – on Moderna’s contracts.
Moderna contracts - Part 1 - by Sasha Latypova (substack.com)
Part 2 Moderna Contracts - by Sasha Latypova (substack.com)
From Part 1
“This contract was signed on April 16, 2020.” … “The contract was originally for ~$500M but later amended to ~$1B (July 2020).” … “The amount of money is absolutely staggering for a company that had no success record, no products on the market or even in late phases of clinical development, and no scaled manufacturing at the time.”
Quite what had been going on between Moderna and the US DoD (BARDA and or DARPA?) since 2011 is anyone’s guess.
“The scope can be summarized as a “contract R&D services for the US Government”. The Government is ordering and paying for pre-clinical, Phase 2 and 3 clinical studies and related CMC (Chemistry, Manufacturing and Controls) development.”
The Vaccine Research Centre at the NIH conducted the animal trials and the Phase 1 clinical trial. “NIH co-own the product, get payouts from Moderna ($400M recently, split with Dartmouth), and then the government buys the product at inflated prices …”
So, there’s one “cross-over”/collaboration between the US military and civilian health authorities.
Moderna’s share price tracked between 14 and 20 bucks prior to March 2020.
(Sasha references a “manager” of the DoD contracts called ATI – who received a nice fat check regardless of the performance of Moderna.)
“$500M-$1B split into 3 line items? Please! Can you see extremely suspect money transfers from the US Government to a “preferred” and co-owned corporate entity for vaguely defined activities under a panic scenario? Not to mention that by 2020 Moderna had already received $5 billion+ in investments and R&D grants (including another ~$500M from DARPA and BARDA) and still had no products! What was all this money for?”
My “spidey senses” tell me that Moderna is a construct – made of whole cloth – of the military to siphon off taxpayer dollars into the pockets of those involved in a conspiracy to defraud the American people.
“This contract does not include the cost of manufacturing of the shots, as those costs were in the second contract by which the government bought millions of shots.”
Part 2 of Sasha’s work goes over the manufacturing of the experimental modified mRNA C19 injections and the payments for these injections.
How did Moderna perform its manufacturing? One of its contractors performed badly.
You can take a few one-week subscription to Hadley’s SubStack to read his article from September 2022.
Which I covered here:
Recall of Moderna C19 Injections? - by Peter Halligan (substack.com)
Observations 1, 3 and 4 from the twelve raised in the FDA Form 483.
OBSERVATION 1
Your firm failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications, whether or not the batch has already been distributed.
OBSERVATION 3
Control procedures are not established which monitor the output and validate the performance of those manufacturing processes that may be responsible for causing variability in characteristics of the in-process material and the drug product.
OBSERVATION 4
Acceptance criteria for the sampling and testing conducted by the quality control unit is not adequate to ensure that batches of the drug product meet appropriate statistical quality control criteria as a condition for their approval and release.”
The above is a cross over from the FDA into a contractor for Moderna – you can interpret that as an investigation by a federal health authority into the workings of a military sub-contractor! I do not know whether the plant corrected these observations or has been subject to more inspections to ensure that it did correct these observations.
Side note: I do wonder about whether the “shake, rattle and roll” of highly unstable mRNA solutions that had to be loaded, transported and unloaded into a million freezers – at minus 80 degrees C - around the world was monitored. Was it a US military operation – maybe subcontracted to several transport companies as well?
The “emergency” meant that these laws could be ignored:
21 U.S. Code § 351 - Adulterated drugs and devices | U.S. Code | US Law | LII / Legal Information Institute (cornell.edu)
21 U.S. Code § 360d - Performance standards | U.S. Code | US Law | LII / Legal Information Institute (cornell.edu)
We know the Pfizer/BioNTech doses were adulterated with SV40 and were contaminated with endotoxins, e-coli etc.
Remember this?
Japan finds black particles in Moderna vaccine - BBC News
“A pharmacist saw several black particles in one vial of the vaccine in Kanagawa Prefecture, according to authorities.
Some 3,790 people had already received shots from the batch. The rest of the batch has now been put on hold.”
The Japanese health regulators had the authority to withdraw injections about to be made.
Let’s close off with a look at Bancel’s salary and Moderna’s financials.
From here:
Of note is the drop in cash, though, of course, this can be topped up at a moment’s (PHEIC) notice.
At tis current rate of cash burn, there will be none by 31 December 2024!
So, how does the stock market price all these circular flows and risks?
MRNA 121.91 +4.60 +3.92% : Moderna Inc - MSN Money
Well, well. Balance sheet assets of 18 billion dollars can produce sufficient future net cash flows that can be discounted to present value of 47 billion dollars – coincidentally starting from a reduction in cash of 3.6 billion in Year 0.
About Becnel’s salary. From last year in April 2023.
Moderna CEO Stéphane Bancel earned nearly $400 million -- and a raise. - The Washington Post
Moderna’s billionaire CEO reaped nearly $400 million last year. He also got a raise.
Vaccine-maker faces pushback over executive pay as CEO pledges to donate proceeds of stock sales to charity.
Any sales of stock from stock options going to charity? That’s nice.
You can compare the story from WaPo with this:
Moderna CEO Stéphane Bancel gets a $1.2M bump in pay to $19.4M (fiercepharma.com)
“UPDATED: Moderna CEO Stéphane Bancel earned $19.4M in 2022 but made much more in stock sales.”
Here’s a chart of Moderna’s stock price.
Makes you wonder if Bancel considers the NIH a charity to which he donated 400 million in cash!
So, Moderna is a creature created by the US DoD, it’s CEO helped design and build the Wuhan Institute of Virology’s lab, someone in the US DoD awarded it billions of dollars to pretend to make an mRNA injection which killed millions.
Very little work has been done on the relative harms caused per manufacturer. We know the Oxford/AstraZeneca shot was pulled after just 6 months in the EU because of its clear lethality, but we don’t know how much more harmful it was compared to Pfizer and Moderna.
Here is an old article that took a shot (sic) at it. Note the under-reporting factor to the EUDA system is far higher than that of VAERS – at around 70 v 40.
From November 2022 here:
Last point: have there been any studies comparing the adverse events reported to the adverse event rates in each of the clinical trials?
Onwards!!!
Please take a paid subscription or forward this article to those you think might be interested. You can also donate via Ko-fi – any amount from three dollars upwards. Ko-fi donations here: https://ko-fi.com/peterhalligan
great article - maybe correct Becnel to Bancel